Find uplifting stories about heroes, innovations, and solutions
14448 results for "psychedelics research"
A new executive order cuts red tape for scientists studying psychedelic compounds like MDMA and psilocybin as treatments for depression, PTSD, and addiction. The breakthrough also includes $50 million for research into ibogaine, a powerful substance showing promise for opioid addiction.
President Trump signed an order in April to speed up research into psychedelic treatments for mental health conditions, offering new hope for veterans and others struggling with depression and PTSD. Scientists are cautiously optimistic about the medical potential while carefully studying safety.
President Trump will sign an executive order Saturday to advance research into psychedelics like psilocybin and ibogaine for therapeutic use. The move could open doors for controlled access to these promising mental health treatments.
President Trump signed an executive order to speed up research and potential FDA approval of psychedelic therapies for veterans suffering from PTSD, depression, and addiction. While the move brings hope to those who've exhausted traditional treatments, experts emphasize these therapies still need rigorous testing in controlled settings.
Over 60% of U.S. voters now strongly support making psychedelics easier to study for medical use, a 14-point jump from 2023. The shift reflects growing public curiosity about therapeutic benefits of substances like psilocybin and MDMA.
A sweeping executive order is accelerating psychedelic research for mental health treatment, unlocking funding and pathways that researchers have sought for years. The question now: Can scientists deliver on the promise fast enough to help those in crisis?
Researchers analyzed over 500 brain scans and discovered a common "neural fingerprint" across LSD, psilocybin, and three other psychedelics. This breakthrough could strengthen clinical trials testing these substances for depression and PTSD.
President Trump signed an executive order to accelerate research into psychedelic drugs for mental health treatment, directing $50 million to state programs. Veterans and advocacy groups hope the move could unlock new treatments for PTSD and depression.
New research shows psychedelics like psilocybin and MDMA could help people with PTSD recover in hours instead of months by actually rewiring trauma-affected brain systems. Clinical trials reveal 67% of patients no longer met PTSD criteria after MDMA-assisted therapy, offering hope to 12 million Americans struggling with the condition.
President Trump signed an executive order directing federal agencies to speed up approval of psychedelic therapies for PTSD, backed by $50 million in new research funding. The move could bring relief to millions of veterans and trauma survivors as soon as this summer.
Leading autism researchers and advocates formed a new independent committee to guide autism research priorities and counter recent federal changes. The group aims to unite the autism community and protect evidence-based research as funding reaches $568 million annually.
A Tibetan lama with 54,000 hours of meditation experience showed identical brain patterns during deep meditation and a low dose of psychedelics. The discovery could help scientists understand consciousness and make meditation benefits more accessible.
%2Fhttps%3A%2F%2Ftf-cmsv2-smithsonianmag-media.s3.amazonaws.com%2Ffiler_public%2F1b%2Fd1%2F1bd13e5f-b965-47b7-85a7-c1e653cecb61%2Ftobacco.jpg)
Researchers engineered tobacco plants to produce five therapeutic psychedelics, making it easier to study treatments for depression and PTSD. The breakthrough could replace harmful harvesting practices with sustainable medicine production.
A scientist who revolutionized protein research is now tackling science's reproducibility crisis with AI. His new approach could help researchers separate reliable studies from questionable ones, speeding up cures for diseases like Alzheimer's.
Scientists now have access to an AI tool that filters through 150 years of research data to deliver trustworthy answers in seconds. CAS Newton helps researchers move from question to verified answer without drowning in information overload.
When US funding cuts threatened to collapse decades of life-saving health research in South Africa, the country fought back with a $32 million rescue package. Now 59 critical HIV and tuberculosis research projects are moving forward.
Researchers engineered a single tobacco plant to produce five therapeutic psychedelic compounds, creating a sustainable alternative to harvesting endangered toads and mushrooms. This biological factory could revolutionize mental health treatment access.
South Korea is creating a new research movement to produce globally recognized scientists like Jane Goodall by focusing on uniquely Korean topics. The K-Science initiative aims to blend the nation's culture, history, and environment with cutting-edge research.
A groundbreaking trial shows military veterans experiencing dramatic improvements in PTSD symptoms after just one session with ibogaine, a powerful natural psychedelic. The research could open new doors for millions struggling with treatment-resistant trauma.
Jennifer Ferris transformed a "Wild Wild West" research environment into a thriving 17-person operation, earning the first university-wide staff award ever given to UT Health Sciences' Knoxville campus. Her journey from solo clinical trial coordinator to award-winning director shows how one person's vision can reshape an entire research community.
Showing 20 of 14448